Vivani director granted 36,516 stock options

Vivani Medical, Inc. director Daniel Bradbury received an annual grant of non-qualified stock options as part of the company’s Non-Employee Director Compensation Policy.

Rhea-AI Filing Summary

Vivani Medical, Inc. director Daniel Bradbury received an annual grant of non-qualified stock options as part of the company’s Non-Employee Director Compensation Policy. The award covers 36,516 options to buy common stock at an exercise price of $1.22 per share, representing 36,516 underlying shares.

The option vests in full on the earlier of the first anniversary of the grant or the next annual meeting of stockholders, subject to his continued service as a director. Following this grant, Bradbury holds 36,516 options, and the options are scheduled to expire on June 23, 2036.

Insider Trade Summary

Grant/Award: 36,516 shares

Grant/Award 1 txn

Insider BRADBURY DANIEL

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy)	36,516	$1.22	$45K

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 36,516 contracts (Direct)

Footnotes (2)

1. F1. Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.
2. F2. The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date.

Key Figures

Options granted: 36,516 options Exercise price: $1.22 per share Underlying shares: 36,516 shares +3 more

6 metrics

Options granted 36,516 options Non-qualified stock option grant to director Daniel Bradbury

Exercise price $1.22 per share Strike price for newly granted options

Underlying shares 36,516 shares Common stock underlying the option grant

Total options after grant 36,516 options Options held by Bradbury following the transaction

Expiration date June 23, 2036 Option term end date

Vesting trigger 1 year or next annual meeting Earlier of first anniversary or next stockholder meeting

Key Terms

Non-Qualified Stock Option, Non-Employee Director Compensation Policy, vests in total, annual meeting of stockholders

4 terms

Non-Qualified Stock Option financial

"Non-Qualified Stock Option (right to buy)"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

Non-Employee Director Compensation Policy financial

"Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy."

vests in total financial

"The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting"

annual meeting of stockholders financial

"the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders"

FAQ

What insider transaction did Vivani Medical (VANI) report for Daniel Bradbury?

Vivani Medical reported that director Daniel Bradbury received a grant of 36,516 non-qualified stock options. These options allow him to acquire 36,516 shares of common stock at an exercise price of $1.22 per share as part of director compensation.

What is the exercise price and size of Daniel Bradbury’s new options at Vivani Medical (VANI)?

Daniel Bradbury was granted 36,516 non-qualified stock options with an exercise price of $1.22 per share. Each option corresponds to one share of Vivani Medical common stock, giving him potential future ownership of 36,516 additional shares if exercised.

How and when do Daniel Bradbury’s Vivani Medical (VANI) options vest?

Bradbury’s option grant vests in full on the earlier of the first anniversary of the grant or the next annual meeting of stockholders. Vesting is conditioned on his continued service as a non-employee director through that vesting date under the company’s policy.

When do Daniel Bradbury’s newly granted Vivani Medical (VANI) options expire?

The options granted to Daniel Bradbury are scheduled to expire on June 23, 2036. If he does not exercise them by that expiration date, they will lapse and no longer give him the right to purchase Vivani Medical common shares at $1.22.

How many Vivani Medical (VANI) options does Daniel Bradbury hold after this grant?

After this grant, Daniel Bradbury holds a total of 36,516 stock options in Vivani Medical. This amount matches the size of the new award, indicating this grant represents his entire option position as reflected in the reported Form 4 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 07:40 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRADBURY DANIEL

(Last) (First) (Middle)

C/O VIVANI MEDICAL, INC.

1350 S. LOOP ROAD

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$1.22	06/24/2026		A		36,516		(1)(2)	06/23/2036	Common Stock	36,516(2)	$1.22(2)	36,516(2)	D

Explanation of Responses:

1. Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.

2. The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date.

	/s/ Anthony Baldor, Attorney-in-fact	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)